Gelita debuts bioactive collagen peptides for immune health

February 1, 2021
Sebastian Krawiec

Gelita recently added Immupept to its line of bioactive collagen peptides. The new ingredient features optimized peptide profiles for stimulation of collagen-rich connective tissues involved with immune response.

Gelita (Eberbach, Germany) recently hosted a webinar sharing new scientific evidence for the role of collagen to support immune health. Collagen-rich tissues such as skin and bones play a significant role in the immune system, says Gelita. For example, skin is the body’s most important barrier, and acts as the first line of defense, while bones contain bone marrow from which all the cells of the immune system are derived.

For this reason, Gelita recently added Immupept to its line of bioactive collagen peptides. The new ingredient features optimized peptide profiles for stimulation of collagen-rich connective tissues involved with immune response. Immupept 25 is designed to stimulate keratinocytes, the cells that maintain the skin’s barrier of defense, and fibroblasts, the cells that regulate the biosynthesis of several functional extracellular matrix proteins involved with immune response. Immupept 50 provides an added benefit with specific peptides that stimulate the specific bone-remodeling cells that maintain health bones which are important for the bone-immune system interplay.

To learn more about Immupept and how bioactive collagen peptides support immune health, you can watch Gelita’s webinar on-demand.